In this episode of Skin Anarchy, host Dr. Ekta sits down with Dr. Azam Anwar, an interventional cardiologist turned skincare innovator, to discuss the groundbreaking origins of CLn SkinCare. What started as a personal battle with a stubborn skin infection transformed into a science-backed skincare line redefining how we approach skin health. Dr. Anwar shares how his background in cardiology and wound healing research led to the development of CLn’s sodium hypochlorite-based formulas, designed to target inflammation, microbial overgrowth, and sensitive skin conditions.

Dr. Anwar reveals the science behind CLn’s hero ingredient, sodium hypochlorite, a diluted bleach compound known for its powerful antimicrobial and anti-inflammatory properties. Unlike traditional cleansers, CLn’s formulations balance efficacy with gentleness, making them safe even for the most sensitive skin types, including children with severe eczema. From tackling infections in athletes to managing conditions like psoriasis and folliculitis, CLn has proven itself a versatile and effective solution backed by robust clinical research.

Throughout the episode, Dr. Anwar emphasizes the importance of medical rigor in skincare. By collaborating with dermatologists and conducting pediatric trials, CLn earned its credibility as a go-to for individuals prone to skin infections, rashes, or inflammation. Whether you’re an athlete, a parent managing a child’s eczema, or someone seeking a dermatologist-approved routine, CLn’s story demonstrates the power of blending advanced science with everyday practicality.

Tune in to discover how CLn SkinCare is changing the skincare game with its innovative approach to healthy, resilient skin.

To learn more about CLn Skincare, visit their website and social media. Don’t forget to subscribe to Skincare Anarchy on Apple Podcasts, Spotify, or your preferred platform. Reach out to us through email with any questions.

Shop all our episodes and products mentioned through our ShopMy Shelf!

Hosted on Acast. See acast.com/privacy for more information.